Physician

Pediatric Pulmonology

Doctor Philip M. Farrell, MD is an expert in the field of Pediatric Pulmonology. He studied medicine at Saint Louis University School of Medicine. Saint Louis University School of Medicine has a rank of 67 in research and a 57 in primary care He over the years received 1 awards: "Whos Who in Medicine and Healthcare". Philip Farrell is a published physician. He published 72 publications, including: 'Challenges in Cystic Fibrosis Newborn Screening and Recommendations for Primary Care Physicians.'

Publications

---

• Challenges in Cystic Fibrosis Newborn Screening and Recommendations for Primary Care Physicians.
• Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.
• Improving the quality of physician communication with rapid-throughput analysis and report cards.
• Risk Factors for the Progression of Cystic Fibrosis Lung Disease throughout Childhood.
• Long-term follow-up of cystic fibrosis newborn screening: Psychosocial functioning of adolescents and young adults.
• Health-related quality of life in children and adolescents with cystic fibrosis: convergent validity with parent-reports and objective measures of pulmonary health.
• Assessing drug costs for use in comparative effectiveness research.
• Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis.
• Wisconsin's Lifecourse Initiative for Healthy Families: Application of the Maternal and Child Health Life Course Perspective Through a Regional Funding Initiative.
• Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9-19years.
• Effects of Immediate Telephone Follow-Up with Providers on Sweat Chloride Test Timing after Cystic Fibrosis Newborn Screening Identifies a Single Mutation.
• The Sensitivity of Lung Disease Surrogates in Detecting Chest CT Abnormalities in Children With Cystic Fibrosis.
• Regional differences in the evolution of lung disease in children with cystic fibrosis.
• Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening.
• Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies.
• Associations Between Academic Achievement and Psychosocial Variables in Adolescents With Cystic Fibrosis.
• Improving communication between doctors and parents after newborn screening.
• Chest CT Scores of Severity are Associated with Future Lung Disease Progression in Children with CF.
• Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Sc...
• Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.
• Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14years of newborn screening.
• The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis.
• Relationships among Health-Related Quality of Life, Pulmonary Health, and Newborn Screening for Cystic Fibrosis.
• Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.
• Long-term evaluation of genetic counseling following false-positive newborn screen for cystic fibrosis.
• Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci.
• Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.
• Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.
• Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.
• Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis.
• The meaning of "early" diagnosis in a new era of cystic fibrosis care.
• Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis.
• Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test.
• Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis.
• Assessing the cost of cystic fibrosis diagnosis and treatment.
• Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
• Quality of life of children with cystic fibrosis.
• The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
• Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.
• Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!
• Plan to address physician shortage requires proper support.
• Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
• Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
• Much more research needed on injury prevention.
• Multiplexed genetic analysis using an expanded genetic alphabet.
• Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.
• Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.
• Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?".
• Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis.
• Welcoming incremental, measurable change.
• Excellent progress has been made but significant challenges remain.
• Using science to improve health care delivery and patient care.
• Celebrating the importance of medical history.
• Newborn screening for cystic fibrosis: ensuring more good than harm.
• Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.
• Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.
• Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
• Assessing personal qualities in medical school admissions.
• A fruitful and gratifying collaboration.
• Using the power of genetics, genomics and molecular biology to fight cancer.
• New research, perspectives required to understand impact of gender on health.
• Matriculating student perceptions of changes to the admissions interview process at the University of Wisconsin Medical School: a prospective, controlled comparison.
• Prenatal screening for cystic fibrosis: where are we now?
• Delayed diagnosis of US females with cystic fibrosis.
• Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
• Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.
• Mission aligned management and allocation: a successfully implemented model of mission-based budgeting.
• Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.
• Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
• Preparing for bioterrorism.
• Enhancing men's urologic health.

Schools

---

• Saint Louis University School Of Medicine

• University Wisc Hosps

• National Institute Amdd

Doctors Specialties

---

• Neonatal Medicine
• Pediatric Pulmonology

Accepted Insurances

---

Awards

---

• Whos Who in Medicine and Healthcare

Education

---

• University of Wisconsin
• Saint Louis University School of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. David S. Shoberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Alliya A. Mohamed, MD This Doctor is OpenDoctor Recommended.
	Olachi J. Mezu-Ndubuisi This Doctor is OpenDoctor Recommended.
	Amjad S. Tuffaha, MB
	Dr. Don A. Bukstein, MD This Doctor is OpenDoctor Recommended.
	Dr. James G. Merrick, MD
	Dr. Mary E. Bussey, MD This Doctor is OpenDoctor Recommended.
	Dr. Marie R. Weinstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Pamela J. Kling, MD This Doctor is OpenDoctor Recommended.
	Dr. Kelly J. Cowan, MD
	Dr. Paola J. Fliman, MD This Doctor is OpenDoctor Recommended.
	Dr. Frank R. Greer, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Christopher G. Green, MD
	Dr. Don B. Sanders, MD
	Dr. Karl F. Szewczyk, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas A. Wilson, MD
	Dr. Matthew W. Harer, MD
	Dr. Olachi J. Mezu-Ndubuisi, MD
	Dr. Princy Ghera, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog